Background and aims: Cyclooxygenase 2 (COX-2) and prostaglandins (PGs) participate in the pathogenesis of inflammatory postoperative ileus. We sought to determine whether the emerging neuronal modulator COX-2 plays a significant role in primary afferent activation during postoperative ileus using spinal Fos expression as a marker.
Methods: Rats, and COX-2+/+ and COX-2−/− mice underwent simple intestinal manipulation. The effect of intestinal manipulation on Fos immunoreactivity (IR) in the L5-S1 spinal cord, in situ circumference, and postoperative leucocytic infiltrate of the intestinal muscularis was measured. Postoperative PGE2 production was measured in peritoneal lavage fluid. The dependence of these parameters on COX-2 was studied in pharmacological (DFU, Merck- Frosst, selective COX-2 inhibitor) and genetic (COX-2−/− mice) models.
Results: Postoperative Fos IR increased 3.7-fold in rats and 2.2-fold in mice. Both muscularis leucocytic infiltrate and the circumference of the muscularis increased significantly in rats and COX-2+/+ mice postoperatively, indicating dilating ileus. Surgical manipulation markedly increased PGE2 levels in the peritoneal cavity. DFU pretreatment and the genetic absence of COX-2−/− prevented dilating ileus, and leucocytic infiltrate was diminished by 40% with DFU and by 54% in COX-2−/− mice. DFU reversed postsurgical intra- abdominal PGE2 levels to normal. Fos IR after intestinal manipulation was attenuated by approximately 50% in DFU treated rats and in COX-2−/− mice.
Conclusions: Postoperatively, small bowel manipulation causes a significant and prolonged increase in spinal Fos expression, suggesting prolonged primary afferent activation. COX-2 plays a key role in this response. This activation of primary afferents may subsequently initiate inhibitory motor reflexes to the gut, contributing to postoperative ileus.
- Fos expression
- postoperative ileus
- COX-2, cyclooxygenase 2
- MPO, myeloperoxidase
- PG, prostaglandin
- KO, knockout
- MDH, medial dorsal horn
- LDH, lateral dorsal horn
- DCM, dorsal commissure
- SPN, sacral parasympathetic nucleus
- IR, immunoreactivity
- iNOS, inducible nitric oxide synthase
Statistics from Altmetric.com
- COX-2, cyclooxygenase 2
- MPO, myeloperoxidase
- PG, prostaglandin
- KO, knockout
- MDH, medial dorsal horn
- LDH, lateral dorsal horn
- DCM, dorsal commissure
- SPN, sacral parasympathetic nucleus
- IR, immunoreactivity
- iNOS, inducible nitric oxide synthase
Postoperative ileus remains an almost universal consequence of abdominal surgery leading to significant morbidity and patient discomfort, which prolongs hospitalisation and thus adds markedly to healthcare costs.1 Inflammatory and neuronal mechanisms have been implicated in postoperative dysmotility but the sequence of these events and their relative contribution to the pathogenesis remain poorly understood. Neural pathways, including spinal reflexes,2,3 neuropeptides,4 nitric oxide,5 and adrenergic receptors,6,7 have been found to play an important role in the development of this disorder. Our laboratory has focused on local inflammatory mechanisms within the intestine, showing in both humans and rodents that surgical manipulation of the gut leads to a marked molecular and cellular inflammatory response within the intestinal muscularis.5,8–10 The resulting inflammatory response has been shown to be proportional to the degree of gut ileus, as demonstrated by a decrease in gastrointestinal transit and suppression of in vitro circular smooth muscle contractility. We have also shown that leucocyte adhesion molecule blocking antibodies prevent the recruitment of monocytes, neutrophils, and mast cells into the muscularis and also avert postoperative jejunal muscle dysfunction.11 This observation underlines the importance of inflammatory changes within the intestinal muscularis in the aetiology of postoperative ileus. More recently, it has been demonstrated that leucocyte derived inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) play a significant role in the pathogenesis of rodent postoperative ileus.5,12,13 It was demonstrated that intestinal manipulation induces iNOS and COX-2 messenger RNA and protein within resident muscularis macrophages and recruited monocytes. Pharmacological inhibition or genetic manipulation of either iNOS or COX-2 resulted in improved postoperative in vitro jejunal circular muscle contractility and prevention of the postsurgical delay in gastrointestinal transit.
Various products released from leucocytes have been demonstrated to sensitise or even directly activate intestinal primary afferent neurones. Reactive radicals, such as superoxide, peroxynitrite, and hydrogen peroxide, generated by leucocytes during inflammation or ischaemia,14 have been shown to stimulate afferent splanchnic C fibre units.15 More recently, prostaglandins, secreted by various leucocyte populations during inflammation,14 have been shown to enhance primary afferent nerve firing. In particular, prostaglandin E2 (PGE2) has been demonstrated to have complex effects on primary intestinal afferents.16–18 Cyclooxygenases are key enzymes in the production of prostaglandins, catalysing the conversion of arachidonic acid to prostaglandins (PG) G2 and H2. Two COX isoforms have been identified and are referred to as COX-1 and COX-2. While COX-1 is produced constitutively, COX-2 is a highly inducible enzyme, known to be triggered in many inflammatory states.19 COX-2 has been shown to be induced by interleukin 1, bacterial lipopolysaccharide, and growth factors.20 Macrophages, one of the main leucocyte populations involved during inflammation of the muscularis after gut manipulation,9 express large increases in numerous proinflammatory cytokines, nitric oxide, and PGs.14 Recently, we have shown that PGs, through induction of COX-2, play a major role in causing postoperative ileus.12 Our data demonstrate that COX-2 inhibitors significantly improved the postsurgical suppression in small intestinal motility.
Fos is a nuclear phosphoprotein product of the immediate early gene Fos which may be used as a specific reproducible marker to map functional excitatory pathways in the central nervous system.21 We hypothesise that upregulation of COX-2 and subsequently PG production within the intestinal wall after intestinal manipulation will increase spinal Fos expression suggesting stimulation of primary afferents, thus increasing their activity and possibly enhancing inhibitory motor reflexes to the gut. This hypothesis is based on experimental data obtained from other gastrointestinal inflammatory models which have shown that inflammation of the gut wall stimulates afferent pathways to the spinal cord using Fos expression as a marker.22–24 To investigate this hypothesis, we determined the effect of intestinal manipulation on activation of primary intestinal afferents by measuring Fos-like immunoreactivity (IR) in the lumbosacral spinal cord. Next we studied events within the gut wall that could contribute to the increased activity of intestinal primary afferents. We determined the leucocytic infiltrate in the intestinal muscularis using myeloperoxidase (MPO) staining after intestinal manipulation and measured the in situ intestinal muscularis circumference. Subsequently, we quantified intra-abdominal release of PGE2 postoperatively. The dependence of these responses on COX-2 was then studied in pharmacological (5,5- dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furan; DFU, Merck-Frosst, selective COX-2 inhibitor)25 and genetic (COX-2−/− mice) models of postoperative ileus.
Sprague-Dawley male rats (220–300 g) were obtained from Harlan (Indianapolis, Indiana, USA). Homozygous wild-type C57BL/6 mice as well as homozygous COX-2−/− knockout (KO) mice weighing 18–20 g were kindly provided by Dr SH Graham (Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA). The homozygous COX- 2−/− KO mice resulted from a cross of COX-2+/− heterozygote C57BL/6 mice (B6,129S- Ptgs2tm1Jed; Jackson Laboratories, Bar Harbor, Maine, USA).26–28 The University of Pittsburgh Institutional Animal Care and Use Committee approved all experimental animal protocols. Animals were housed in a pathogen free facility that is accredited by the American Association for Accreditation of Laboratory Animal Care and complies with the requirements of humane animal care, as stipulated by the United States Department of Agriculture and the Department of Health and Human Services. They were maintained on a 12 hour light/dark cycle and provided with commercially available chow and tap water ad libitum. Genotypes of mice were determined on DNA isolated from tail clippings, using previously described protocols.27,28
Experimental groups and operative procedures
The small bowel of the animals was subjected to an easily standardised mild surgical manipulation, as described previously.9 Unoperated animals served as corresponding controls. In brief, before the beginning of surgery, animals were anaesthetised with isoflurane inhalation and a midline incision was made into the peritoneal cavity. The small bowel was eventrated to the left onto moist gauze, and the entire small bowel was lightly manipulated between two moist cotton applicators. After manipulation, laparotomy of each animal was closed using a double layer running suture. The bowel manipulation procedure caused no mortality. Animals recovered quickly from surgery and generally began to eat and drink within two hours. For this study, animals were sacrificed 24 hours after manipulation. This time point was chosen as it has been previously shown that the postoperative leucocyte infiltrate in the intestinal muscularis is fully developed.29 We also chose this later time point as we wanted to study specifically the interaction of postoperative inflammation with intestinal primary afferents, without any immediate interference from possible mechanical stimulation of primary intestinal afferents by the surgical procedure itself. The highly selective COX-2 inhibitor DFU (Merck-Frosst) was dissolved in DMSO and administered at 10 mg/kg subcutaneously, 30 minutes before intestinal manipulation and again four hours postoperatively. The rat experiments included four groups of animals (each n=4–6): controls; controls treated with DFU; rats undergoing intestinal manipulation; and rats undergoing intestinal manipulation treated with DFU. For experiments measuring Fos IR in the spinal cord, a fifth experimental group was added consisting of animals undergoing laparotomy only without intestinal manipulation (n=4). The mouse experiments consisted of four experimental groups: COX-2+/+ and COX-2−/− mice underwent small bowel intestinal manipulation. Unoperated COX-2+/+ and COX-2−/− mice were used as controls.
Histochemistry stainings for MPO activity and measurement of the in situ circumference of the intestinal muscularis
Whole mounts of the intestinal muscularis from paraformaldehyde perfused animals were investigated for the presence of resident and recruited leucocytes. Mid jejunal segments approximately 3–4 cm in length were cut from the bowel and immersed in chilled KRB in a Sylgard bottom coated glass dish (Dow-Corning, Midland, Michigan, USA). The segment was gently pinned down along the mesenteric border. The bowel was opened along the mesentery and washed twice in Krebs buffer, and mucosa and submucosa were stripped off under microscopic observation (Wild-M8, Heerbrugg, Switzerland). The mucosa free muscularis whole mounts were used for staining procedures. Polymorphonuclear neutrophils were visualised by a MPO stain: freshly prepared whole mounts were immersed in a mixture of 10 mg Hanker-Yates reagent (Sigma Chemical Co, St Louis, Missouri, USA), 10 ml KRB, and 100 μl 3% hydrogen peroxide (Sigma) for 10 minutes. The reaction was stopped with cold Krebs. Whole mounts were cover slipped and inspected by light microscopy after staining (Nikon FXA; Fryer, Huntley, Illinois, USA). Leucocytes were counted in five randomly chosen areas in each specimen at a magnification of 200×. The in situ circumference of the muscularis was measured by determining the greatest width of each muscularis whole mount with a caliper.
Measurement of PGE2 in peritoneal lavage fluid
Intra-abdominal release of PGE2 was determined in controls and in rats 24 hours after intestinal manipulation with and without DFU treatment. The peritoneal cavities of these two groups were injected with 4 ml of warmed sterile isotonic sodium chloride solution (Abbott Laboratories, North Chicago, Illinois, USA) and the animal was then sacrificed after a period of 90 minutes. At the time of sacrifice the peritoneal liquid was aspirated and the concentration of PGE2 was measured by ELISA (Amersham Pharmacia Biotech Inc., Piscataway, New Jersey, USA).
Measurement of Fos immunoreactivity (IR)
Twenty four hours after intestinal manipulation, animals were anaesthetised (pentobarbital 50 mg/kg intraperitoneally) and sacrificed via intracardiac perfusion first with Kreb’s buffer followed by 4% paraformaldehyde fixation. The spinal cord L5–S1 was removed and postfixed overnight in the same fixative at 4°C. Tissues were subsequently cryoprotected in 30% sucrose solution overnight at 4°C and embedded in OCT embedding medium (Tissue- Tek; Sakura Finetek Inc., Torrance, California, USA). Alternate floating sections (30 μm) of the spinal cord L5–S1 were processed for Fos IR, as described previously,30,31 using an avidin-biotin method for the Fos protein with primary antibodies at a dilution of 1:60 000 (Calbiochem, La Jolla, California, USA) and goat antirabbit secondary antibodies at a dilution of 1:600 (Vector, Burlingame, California, USA).
Counts of Fos positive cells on one side of the spinal cord are presented as the cumulative mean of all three segments. The number of labelled neurones was estimated from counts of positively stained cells in a minimum of 10 sections per spinal cord segments. Sections used for the counts were separated by at least 100 μm to eliminate counting of a neurone more than once. Cells exhibiting Fos protein IR were counted in four regions, similar to those described earlier,30–32 for assessing regional distribution: medial dorsal horn (MDH), lateral dorsal horn (LDH) including the superficial laminae I and II, dorsal commissure (DCM) including lamina X, and the sacral parasympathetic nucleus (SPN) including the lateral laminae V–VII (fig 1). Analysis of the regional distribution of Fos IR was limited to the L6 segment, as this had the largest number of cells.
The L5–S1 segment of the spinal cord was chosen as it has previously been shown that primary intestinal afferents from the lower gastrointestinal tract project to this segment.23,24,33,34 To confirm that the majority of neurones expressing Fos postoperatively were in the L5–S1 segments, we quantified Fos expression within the spinal cord segments T10–S2 in two animals postoperatively.
Calculations and statistics
Data are presented as mean (SEM). Changes in the in situ circumference of the intestinal muscularis, MPO positive cells, intra-abdominal PGE2 concentration, and Fos IR were evaluated statistically by ANOVA followed by a Scheffe multiple comparison test using STATA software (STATA corporation, College Station, Texas, USA). Differences in regional distribution of Fos IR between manipulated rats with/without DFU pretreatment and between manipulated COX-2+/+ and COX-2−/− mice were compared by an unpaired Student’s t test. Data were considered statistically significant at p<0.05.
Intestinal manipulation causes a sustained upregulation of spinal cord Fos
We hypothesised that the inflammatory responses within the gut wall cause an increase in spinal Fos expression. To obtain evidence to support this hypothesis, we quantified Fos expression within spinal cord segments T10–S2, 24 hours after selective surgical manipulation of the rat small intestine in a group of rats. These data showed that a significant increase in Fos-like IR was primarily localised to L5–S1 compared with spinal Fos-like IR of control rats. A typical example of the distributed increase in Fos positive spinal neurones of a manipulated animal is shown in fig 2. In control rats, baseline Fos IR cells cumulatively numbered 45.1 (5.71) for spinal cord segments L5–S1. Twenty four hours after intestinal manipulation, a 3.7- fold increase in Fos IR cells was quantified (168.0 (6.90); p<0.001). Laparotomy alone did not have a significant effect on spinal Fos IR 24 hours postoperatively in rats (41.1 (10.6)), indicating that the increase in Fos positive cells in the manipulated animals was directly related to the sequelae of intestinal manipulation rather than to anaesthesia or laparotomy. The largest percentage of postoperative Fos IR was located in the LDH region (37.2 (4.71)%), with smaller percentages in the MDH (22.8 (1.84)%), DCM (22.1 (2.54)%), and SPN, including the lateral laminae V–VII (17.9 (3.66)%). In unmanipulated control rats, total numbers of Fos IR cells were low and regional differences were not significant (approximately 5–10 Fos positive cells per section).
Manipulation induced intestinal circumferential dilatation and leucocyte infiltration
Next, we sought to determine events within the gut wall that could contribute to increased spinal Fos expression. Bowel wall distension is known to activate intestinal afferents23 and typical flat plate abdominal radiographs of patients suffering from postoperative ileus show a dilated bowel.35 As shown in fig 3A and 3B, this clinical observation was recapitulated in our model of postoperative ileus such that compared with controls, intestinal manipulation caused a significant increase in intestinal muscularis in situ circumference in both rats (controls 0.9 (0.1) cm; intestinal manipulation 1.3 (0.1) cm) and wild-type COX-2+/+ mice (controls 0.85 (0.1) cm; intestinal manipulation 1.3 (0.1) cm). Laparotomy in itself did not affect rat intestinal 24 hour postoperative in situ circumferences (1.0 (0.1) cm).
The manipulation induced increase in bowel wall circumference was associated with an increase in MPO positive (MPO+) cells within the muscularis. These types of leucocytes are known to secrete substances which are known to sensitise primary afferents8 and contribute to bowel dysmotility.29 In control rodents, low numbers of MPO+ cells were quantified within the intestinal muscularis (rat: 2.7 (0.34) cells/field; mice: 0.6 (0.27) cells/field at 200× magnification). However, as shown in figs 4 and 5, intestinal manipulation resulted in a significant extravasation of MPO+ cells into the muscularis of both rats and COX-2+/+ mice (rats: 92.6 (12.10) cells/field; COX-2+/+ mice: 58.7 (9.40) cells/field at 200× magnification).
Pharmacological (DFU) and genetic (COX-2−/−) modulation of COX-2
We have previously demonstrated that the inducible COX-2 pathway plays a significant role in postoperative dysmotility.12 Here we show that pharmacological and genetic manoeuvres to limit COX-2 activity significantly prevent intestinal dilation caused by intestinal manipulation. Manipulated rats pretreated with DFU (10 mg/kg) and manipulated COX-2−/− mice did not manifest bowel dilatation and had intestinal circumferences that were comparable with control unmanipulated rodents, as shown above (DFU treated manipulated rats: 1.0 (0.1) cm; COX-2−/− manipulated mice: 0.9 (0.1) cm; n=5 for all groups) (fig 3). DFU administered to control unoperated animals did not alter intestinal circumference (1.0 (0.04) cm) compared with control animals.
Just as manipulation induced dilatation was associated with a strong leucocytic infiltrate, as mentioned above, prevention of dilatation through pharmacological and genetic manipulation of COX-2 was associated with a decrease in leucocyte infiltration into the intestinal muscularis. DFU treated controls or laparotomy alone did not alter the baseline number of MPO+ cells quantified in the muscularis whole mounts (DFU treated controls: 2.1 (0.16) cells/field at 200× magnification; laparotomy only: 2.8 (0.31) cells/field) compared with unoperated controls. Likewise, MPO+ cells were found in low numbers in COX-2−/− mice within the muscularis (0.7 (0.37) cells/field). As shown in figs 4 and 5, the intestinal manipulation induced extravasation of leucocytes into the rat intestinal muscularis was significantly prevented with DFU pretreatment by 40% (53.3 (5.79) cells/field). Similarly, COX-2 deficient mice showed a significant 54% decrease in MPO+ muscularis leucocytic infiltrates after intestinal manipulation (27.2 (5.90) cells/field) compared with manipulated wild-type mice.
DFU prevents the postoperative intra-abdominal production of PGE2
PGE2 is produced by inflammatory cells during inflammation and has been demonstrated to be one of the important factors which sensitise intestinal primary afferents.17 Intestinal manipulation caused a 3.1-fold increase in PGE2 concentration measured in the intraperitoneal lavage fluid of rats 24 hours after surgery (controls 213.3 (26.4) pg/ml; intestinal manipulation 669.0 (62.9) pg/ml; p<0.003) (fig 6). Selective inhibition of COX-2 with DFU did not significantly alter baseline intra-abdominal PGE2 levels measured from peritoneal lavage fluid (200.8 (16.1) pg/ml) but DFU markedly decreased the observed postsurgical increase in PGE2 in the abdomen (260.8 (20.0) pg/ml) after manipulation. Figure 6 illustrates that postoperative PGE2 concentrations in the peritoneal lavage fluid were maintained at baseline levels in both DFU treated groups of animals (p<0.006).
Pharmacological (DFU) and genetic (COX-2−/−) modulation of COX-2 significantly limits the rise in postoperative spinal cord Fos expression
Finally, we sought to determine if the postoperative COX-2 sensitive responses to intestinal manipulation (that is, bowel dilatation, inflammatory infiltrate, and increased intra- abdominal PGE2 levels) contributed to the observed sustained increase in postoperative Fos expression within L5–S1 spinal cord neurones. As shown in figs 7 and 8, pharmacological blockade of COX-2 with DFU did not alter baseline numbers of Fos IR cells (controls 45.1 (5.71) cumulative mean Fos counts L5–S1; DFU treated controls 38.0 (7.36)). However, DFU significantly attenuated by 50% the 3.7-fold increase in Fos IR cells induced by intestinal manipulation (control manipulation 167.90 (6.90) v DFU manipulation 84.3 (3.60); p<0.001, n=5 each). DFU pretreatment markedly reduced the percentage of Fos IR cells in the LDH (25.5 (3.17)%; p<0.05) while the distribution in the MDH (24.6 (2.36)%), DCM (29.3 (2.65%), and SPN (20.6 (3.26)%) were not significantly affected. Figure 8 shows the typical distribution of Fos IR positive cells in four groups of animals (control, manipulated, manipulated with DFU pretreatment, and a laparotomised rats).
Similarly, genetically deficient mice also showed attenuated Fos activation compared with COX-2+/+ wild-type mice. Although baseline Fos IR spinal cord cell counts were similar between COX+/+ (69.0 (4.3) cells) and COX-2−/− mice (61.6 (8.3) cells), manipulated COX- 2−/− mice exhibited 49% fewer Fos IR neurones (77.9 (10.3 cells) compared with manipulated wild-type mice (152.0 (23.30) cells) (fig 7B). No regional predominance in Fos IR in manipulated COX+/+ mice could be distinguished (LDH 26.8 (2.35)%, MDH 23.6 (5.37)%, DCM 25.5 (1.86)%, SPN including the lateral laminae V-VII 24.2 (3.81)%). Additionally, Fos IR was decreased overall in manipulated COX-2−/− mice without a significant preferential decrease in any particular area.
In the present study, we have shown for the first time that COX-2 dependent inflammatory responses play an important role in long term postoperative spinal Fos expression after surgical manipulation of the small intestine. Previous studies have clearly identified the importance of both a neurogenic and a local inflammatory mechanism for causing postoperative ileus. Our current demonstration of the immunological modulation of spinal Fos expression, used as a marker for activation of visceral afferents, creates a mechanistic link between the postoperative inflammatory events that we have previously delineated within the intestinal muscularis5,9,11,12,29 and an inhibitory neuronal reflex that participates in causing postoperative ileus.
Noxious distension, inflammation or chemical irritation of the gastrointestinal tract,22–24,33 urinary bladder,30,31,36 and skin37 have been used to stimulate and map afferent pathways to the spinal cord using Fos expression. These models have been shown to “sensitise” polymodal visceral sensory fibres by reducing their threshold for activation and by increasing their spontaneous and evoked firing rate.38 Additionally, inflammation has been shown to awaken “silent afferent fibres”.39,40 Our data showing an increase in Fos-like IR within the spinal cord 24 hours following surgery suggest that intestinal manipulation, which frequently occurs in a clinical setting, initiates a series of events that results in a prolonged increase in the activation of intestinal primary afferent neurones. However, Fos expression remains an indirect measure to map primary afferent pathways to the spinal cord and several other possibilities need to be considered that could have contributed to the enhanced Fos expression. Limitations of the observed change in Fos expression include the possibility that Fos-like IR could also be centrally mediated through reduced descending inhibition, or through supraspinal or segmental activation.
The distribution of the manipulation enhanced inputs appeared to be predominantly localised to L5–S1 segments of the rat spinal cord. Only the lower small intestine is known to project to this area, while the proximal and mid small bowel projects to the lower thoracic segments. Fos counts were elevated in the T10–T12 segments, but to a lesser degree than in the L5–S1 segments. It is thus possible that afferents from secondary events in the colon, which project mainly to the lumbosacral segments,41 could account for a large portion of the observed change. We have recently shown that selective jejunal manipulation also compromises colonic circular muscle contractility and causes significant upregulation in several inflammatory mediators, including COX-2, in both the gastric and colonic muscularis.42 Thus PG synthesis appears to play an important role in the postsurgical increase in Fos expression in the L5–S1 spinal cord after intestinal manipulation. Neutrophils were also significantly recruited into the gastric and colonic muscularis after selective jejunal manipulation. It is thus conceivable that this panenteric “field effect” plays an important role in why Fos expression is mostly increased in the L5–S1 spinal cord after intestinal manipulation. Clinically, this is also an important observation as colonic ileus is known to occur in patients after selective gastric or small intestinal surgery.43 The effective duration of ileus is also mainly dependent on the return of colonic motility as the average postsurgical paralytic state lasts the longest in the colon.1 Within the L5–S1 spinal segments the largest percentage of postoperative induced Fos IR was located in the LDH, with smaller and relatively equal percentages distributed in the MDH, DCM, and SPN. The spinal distribution of Fos expression after manipulation is similar to other pelvic visceral afferent mapping investigations which report a lumbosacral pattern of neuronal activation that is localised to the MDH, LDH, DCM, and SPN.23,31,44 The fact that we saw Fos expression not only in peripheral, but also deeper laminae, may reflect that at the 24 hour time point there is polysynaptic activation of neurones other than primary afferent neurones involved in processing information from the inflamed intestine. However, it has also been suggested that with ongoing peripheral inflammation Fos expression in the rat spinal cord moves from the more superficial laminae to deeper laminae.45 Together, these results suggest that neurones in several regions of the spinal cord are involved in processing information from afferent inputs of the inflamed intestine.
Visceral sensory nerves have previously been implicated in the development of postoperative ileus. Desensitisation of intestinal primary afferents with capsaicin pretreatment has been shown to reduce the postoperative delay in gastrointestinal transit2 and to increase postoperative motility.3 The neurotransmitter calcitonin gene related peptide, which is released from sensory neurones on stimulation, appears to be a component of this neuronal mechanism in causing postoperative gastric46 and colonic4 ileus. However, in all of these studies gastrointestinal transit or motility measurements were performed within a few hours after surgical manipulation of the gut. Thus it is possible that some of these observations could have been confounded by the immediate activation of mechanoreceptors through the procedure itself or by anaesthesia. The present study showing persistent elevation in spinal Fos expression suggests for the first time that primary intestinal afferents remain activated for at least a 24 hour period postoperatively when the direct effects of mechanical stimulation and anaesthesia have worn off.29 It has previously been shown that spinal Fos expression peaks after a stimulus at about 1–2 hours, and that the number of Fos positive cells declines after six hours returning to control levels 24 hours after the original stimulus.31 Thus the marked increase in spinal Fos-like IR at 24 hours indicates ongoing neuronal activation. This extended time point after surgery may reflect more closely the mechanisms that cause clinical postoperative ileus, which can last several days after surgery.1 In this study we have demonstrated activation of the afferent sensory arm, using Fos expression as a marker, but also propose that stimulation of primary intestinal afferents will subsequently activate inhibitory sympathetic reflexes to the gut contributing to the pathogenesis of postoperative intestinal muscle dysfunction. Autonomic adrenergic pathways have been shown to be involved in the pathogenesis of postoperative ileus6,7,47 as administration of alpha-2 adrenergic antagonists significantly decreased7,47 or even reversed6 postoperative intestinal motility disturbances.
As bowel distension itself is known to activate visceral afferent neurones48 and we observed postoperative dilatation of the bowel following surgery, bowel wall stretch could be one of the factors that contributed to the increase in Fos positive spinal neurones. It is very common for the physician to radiographically observe a significant circumferential enlargement in the postsurgical bowel in a clinical setting.35 We hypothesise that the increase in bowel diameter is mediated by the postsurgical ensuing inflammatory response, which is caused by bowel manipulation. This same inflammatory milieu is known to consist of mediators that have been hypothesised to mechanistically participate in the hyperalgesic response of the gut, which include: histamine, serotonin, tachykinins, prostanoids, cytokines, neurotrophins, and reactive intermediates. Also, many of these mediators are known to be derived from leucocytes.5,12,40,49,50 Based on evidence for direct involvement of prostanoids in sensitising intestinal primary afferents,16–18 in this study we directly measured intra-abdominal levels of PGE2 and our results quantified a significant increase in intra-abdominal PGE2 levels following manipulation.
PGE2 has been found to have an inhibitory effect on gastrointestinal motility both in vivo51–53 and in vitro.54 While a direct inhibitory effect of PGs on jejunal circular muscle has been previously implicated by our findings,12 the present study provides evidence that endogenously produced PGs during postoperative ileus could additionally affect gastrointestinal motility through activation of primary afferents, as evidenced by an increase in spinal Fos expression. This possible activation of primary afferents would subsequently initiate inhibitory motor reflexes to the gut that contribute to postoperative ileus. A similar mechanism has previously been demonstrated in the bladder where it was found that endogenous PGE2 alters the efferent reflex limb of micturition by sensitising capsaicin sensitive afferents.55
Pharmacological and genetic ablation of COX-2 significantly reduced the postoperative inflammatory leucocytic infiltrate within the intestinal muscularis. COX-2 inhibition could have decreased the inflammatory infiltrate by various mechanisms. Although beyond the scope of this investigation, we speculated that as endogenous PGE2 has been shown to stimulate interleukin 6 synthesis in macrophages56 and interleukin 6 has been shown to contribute to leucocyte recruitment during haemorrhagic shock,57 it is conceivable that COX- 2 blockade could attenuate the postoperative leucocytic infiltrate by decreased PGE2 production, which will lead to diminished interleukin 6 levels and thus a decrease in leucocyte recruitment. Additionally, COX-2 inhibitors have also been shown to have anti- inflammatory effects independent of COX-2 activity—for example, through inhibiting proinflammatory transcription factors such as nuclear factor κB.58
Interestingly, anaesthesia and laparotomy together did not affect Fos IR, bowel circumference, muscularis leucocytic infiltrates, or PGE2 levels, thus demonstrating that alterations in these parameters were due to the sequelae of intestinal manipulation rather than anaesthesia or laparotomy. In contrast, experiments in which COX-2 was pharmacologically blocked or was genetically absent demonstrated that bowel dilation, muscularis infiltration, and a subsequent increase in intra-abdominal PGE2 production were mediated by an increase in COX-2 synthase activity. Additionally, the similarity in the observations using pharmacological blockade of COX-2 and COX-2−/− mice indicates that no compensatory pathways developed in COX-2−/− mice in regard to this neuromodulatory function of COX-2.
Others have shown previously that selective COX-2 inhibition can decrease spinal Fos expression after experimentally induced intraplantar inflammation.59,60 Additionally, PGs appear to markedly contribute to the increased afferent discharge activity associated with ischaemia of the gastrointestinal tract.61,62 The present study demonstrates that COX-2 inhibition can decrease spinal Fos expression induced by gut inflammation. This was demonstrated using pharmacological blockade of COX-2 synthase activity and by using COX-2−/− mice, with both experimental manoeuvres decreasing the number of Fos positive neurones by 50%. These data provide further evidence for the concept that COX-2 is an important emerging primary afferent modulator.63
PGE2 has been shown to have a direct effect on mesenteric afferents by interacting with EP receptor subtypes on the afferent receptive field nerve terminals.17 However, the mechanism by which COX-2 activity mediates an increase in primary afferent activity may not only be by a direct effect but could also be through potentiation of bradykinin induced activation of intestinal primary afferents.16,18 Bradykinin is a pain producing peptide generated in tissues following inflammation that is known to stimulate primary afferents within the gastrointestinal tract.64 Recently it has been found that this response is also dependent on the presence of PGE2. Inhibition of COX activity with naproxen significantly reduced the stimulatory effect of bradykinin on serosal afferents and direct application of PGE2 fully restored this response.16 Similarly, as COX-2 inhibition decreased the inflammatory infiltrate, the influence of leucocyte derived reactive intermediates such as superoxides and peroxynitrites would also be diminished and thus lessen their potential effects on altering primary afferent activity.
In conclusion, our study demonstrates for the first time that intestinal manipulation markedly increases spinal Fos expression for a prolonged period postoperatively in two rodent species. COX-2 plays a key role in this response, adding further to the evidence that COX-2 is a multifunctional neuronal modulator. We hypothesise that this may reflect primary afferent activation, initiating subsequently inhibitory motor reflexes to the gut, leading to postoperative intestinal gut dysfunction. Thus the present study shows that prostaglandins provide a crucial link between postoperative intestinal inflammatory mechanisms and activation of neuronal pathways in the pathogenesis of postoperative ileus.
This work was supported by the National Institutes of Health R01-GM58241, P50-GM- 53789, and RO1-DK54824. C Kreiss was supported by the Foundation for Digestive Health and Nutrition/American Gastroenterological Association/AstraZeneca Fellowship/Faculty Transition Award.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.